Markers of insulin resistance are associated with cardiovascular morbidity and predict overall mortality in long-standing non-insulin-dependent diabetes mellitus

Acta Diabetologica

Volumn 35, Issue 1, 1998, Pages 52-56

  Pontiroli, A E ^a   Pacchioni, M ^a   Camisasca, R ^a   Lattanzio, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Coronary heart disease; Epidemiology; Insulin resistance; Non insulin dependent diabetes mellitus; Oral hypoglycemic agents

Indexed keywords

C PEPTIDE; CREATININE; GLUCAGON; HEMOGLOBIN A1C; INSULIN; LIPID; PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH CERTIFICATE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS; RISK FACTOR; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MORBIDITY; PROGNOSIS; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS;

EID: 0031801312     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920050101     Document Type: Article

References (41)

1. De Fronzo RA (1988) The triumvirate ß-cell, muscle, liver; a collusion responsible for NIDDM. Diabetes 37: 667-687
2. Arner P, Pollare T, Lithell H (1991) Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non obese subjects. Diabetologia 34: 483-487
3. Banerji MA, Lebovitz HE (1992) Insulin action in black Americans with NIDDM. Diabetes Care 15: 1295-1302
4. Thoelke H, Ratzmann KP (1989) Häufigkeit des Sekundärversagens einer Sulfonylharnstofftherapie Dtsch Med Wochenschr 114: 580-583
5. Klein R (1995) Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18: 258-268
6. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M (1995) Intensive insulin therapy prevents the progression of diabetic macro-vascular complications in Japanese patients with non-insulin-dependent diabetes mellitus, a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117
7. Andersson DKG, Svardsuud K (1995) Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 18: 1534-1543
8. Colwell JA (1996) The feasibility of intensive insulin management in NIDDM: implications of the Veterans Affairs cooperative study on glycemic control and complications in NIDDM. Ann Int Med 124: 131-135
9. Laakso M (1993) How good a marker is insulin level for insulin resistance. Am J Epidemiol 137: 959-965
10. Stout RW (1990) Insulin and atheroma. 20-yr perspective. Diabetes Care 13: 631-651
11. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-age population. Diabetologia 19: 205-210
12. Pyorala K, Savolainen E, Kaukola S, Haapakoski J (1985) Plasma insulin as coronary heart disease risk factors and predictive value during 9 and 1/2-year follow-up of the Helsinki Policemen Study Population. Acta Med Scand [Suppl] 701: 38-52
13. Welin L, Eriksson H, Jarsson B, Ohlson LO, Svardsudd K, Tibling G (1992) Hyperinsulinemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia 35: 766-770
14. Shinozaki K, Suzuki M, Ikebuchi M, Hara J, Harano J (1996) Demonstration of insulin resistance in coronary artery disease documented by angiography. Diabetes Care 19: 1-6
15. Krolevski AS, Czyzyk A, Jameczko D, Kopczynnski J (1977) Mortality from cardiovascular disease among diabetics. Diabetologia 13: 345-350
16. Ronnemaa T, Laakso M, Pyorala K, Kallio V, Puukka P (1991) High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and non-diabetic subjects. Arterioscl Thromb 11: 80-90
17. Liu QZ, Knowler WC, Nelson RG, Saad MF, Charles MA, Liebow IM, Bennett PH, Pettitt DJ (1992) Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Diabetes 41: 1141-1150
18. Muggeo M, Verlato G, Bonora E, Bressan F, Girotto S, Corbellini M, Gemma ML, Moghetti P, Zenere M, Cacciatori V, Zoppini G, De Marco R (1995) The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 38: 318-325
19. Pontiroli AE, Calderara A, Pozza G (1994) Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management. Diabetes Metab Rev 10: 31-43
20. Prineas RJ, Crow RS, Blackburn H (1982) The Minnesota code of electrocardiographic findings. Standards and procedures for measurement and classification. John Wright, Boston
21. Diabetic Retinopathy Study Research Group (1981) Report 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21: 210-216
22. Faber OK, Binder C (1977) C-peptide response to glucagon. A test for the residual β-cell function in diabetes mellitus. Diabetes 26: 605-610
23. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
24. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, Passeri M, Reaven GM (1993) Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. J Intern Med 234: 25-30
25. Haffner SM, Miettinen H (1997) Insulin resistance implications for type II diabetes and coronary heart disease. Am J Med 103: 152-162
26. Dzurik R, Spustova V, Janekova K (1995) The prevalence of insulin resistance in kidney disease patients before the development of renal failure. Nephron 69: 281-285
27. Standl E, Janka HU (1985) High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. Horm Metab Res [Suppl] 15: 46-51
28. Nosadini R, Cipollina MR, Solini A, Sambataro M, Morocutti A, Doria A, Fioretto P, Brocco E, Muollo B, Frigato F (1992) Close relationship between microalbuminuria and insulin resistance in essential hypertension and non insulin dependent diabetes mellitus. J Am Soc Nephrol 34 [Suppl]: S56-S63
29. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST (1995) Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. Am J Epidemiol 142: 288-294
30. Eschwege E, Balkan B, Fontbonne A (1994) The epidemiology of coronary heart disease in glucose intolerant and diabetic subjects. J Intern Med 236 [Suppl 736]: 5-11
31. Feskens EJM, Kromhout D (1994) Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen elderly study. Arterioscl Thromb 14: 1641-1647
32. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W (1992) Morbidity, mortality, and albuminuria in type 2 diabetic patients; a three-year prospective study of a random cohort in general practice. Diabetic Med 9: 646-653
33. Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43: 960-967
34. Randeree HA, Omar MAK, Motala AA, Seedat MA (1992) Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 15: 1258-1263
35. Piatti PM, Monti LD, Conti M, Baruffaidi L, Galli L, Phan CV, Guazzini B, Pontiroli AE, Pozza G (1996) Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin 1 release in humans. Diabetes 45: 316-321
36. Missov RM, Stolk RP, Van der Bom JG, Hofman A, Boots ML, Pols HAP, Grobbee DE (1996) Plasma fibrinogen levels in NIDDM: the Rotterdam study. Diabetes Care 19: 157-159
37. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM (1992) Metabolic effects of the new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15: 193-203
38. Hermann LS, Schersten B, Bitzen PO, Kjellstrom T, Lindgarde F, Melander A (1994) Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care 17: 1100-1109
39. Pontiroli AE, Pacchioni M, Piatti PM, Cassisa C, Camisasca R, Pozza G (1996) Benfluorex in obese non insulin dependent diabetes mellitus poorly controlled by insulin: a double blind study vs placebo. J Clin Endocrinol Metab 81: 3727-3732
40. Lithell HO (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14: 203-209
41. Pories WJ, Swanson MS, MacDonald KG, Long SB (1995) Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 222: 339-352